Connect with us

Cannabis News

Former Senator Details Psychedelics Conversations With Two Trump Cabinet Members

Published

on

A former US senator says he has personally spoken with the heads of the US Department of Health and Human Services (HHS) and the US Department of Veterans Affairs (VA) about the therapeutic potential of psychedelics such as ibogaine, and both members of President Donald Trump’s cabinet welcomed reform on the issue.

Former Sen. Kyrsten Sinema (I-AZ), who was a Democrat for most of her career in Congress before becoming an independent, said there is a great opportunity under the Trump administration to free up access to psychedelics for therapeutic purposes, Robert F. Kennedy Jr. His “close” relationship with the HHS secretary and swinging around alternative political views.

In an interview with Politico, Sinema spoke about the country’s “magical and unique time” for psychedelic reform at a recent event hosted by Americans for Ibogaine, the advocacy organization co-founded by former Texas Gov. Rick Perry (R).

“Is there an opportunity to do this in this administration? Hell, yes,” he said, adding that Kennedy “is disruptive and supports psychedelic medicine.”

“The opportunity is ripe in this administration, and we should strike while the iron is hot,” said the former lawmaker, who has publicized the therapeutic use of the psychedelic ibogaine.

In addition to Kennedy, Sinema said he advised VA Secretary Doug Collins about the potential of psychedelics to help veterans with serious mental health issues.

“He hadn’t heard of it. He hadn’t even heard of psychedelic medicine,” she said. “He was skeptical at first. He’s a conservative pastor in Georgia. Then he got together with some veterans and saw the science and as you’ve heard, he’s the most prominent proponent of psychedelic medicine in the administration.”

“Historically, I think you’ve seen psychedelics — not necessarily psychedelic medicine — but psychedelics, left-wing hippies dominated,” he said. say Political “Psychedelic medicine as a treatment for disorders is important to many people on the right. I want to be clear: the reason is not because they are psychedelics, but because nothing else works.”

The former senator said that “in a conservative’s brain, psychedelics are not a drug, they are a medicine.”

“In the old-school left-wing psychedelic movement, they’re seen as a drug. That drug has medicinal properties, but it also has other non-medicinal properties that they celebrate,” he said. “I think what you’re seeing from the mainstream blue community is a concern that if they accept psychedelics they’ll look like left-wing weirdos and hippies. It could also be a commitment to mainstream medicine. Politically speaking, it could also be skepticism if conservatives like it.”

As the Arizona legislature advanced an ibogaine research project earlier this year, the former senator—who also championed psychedelic legislation while serving in Congress—.he gathered support for the reformWhile pledging to personally raise $5 million in philanthropic donations to support psychedelic research, if it ultimately materializes.

Last year, a US Department of Veterans Affairs (VA) official, who has since moved into an advisory role, praised Sinema. his “knowledge of psychedelic literature and all related subjects” while praising the agency’s work to advance research into novel therapies.

For his part, Kennedy, the health secretary, he is believed to still use psychedelics, although he is otherwise soberThe following book by a journalist who allegedly had a romantic relationship with her states.

Last month, Kennedy, Vice President JD Vance, the Food and Drug Administration (FDA) commissioner and other Trump administration officials attended the “Make America Healthy Again” summit. it was a session dedicated to studying psychedelic medicine.

While Sinema noted that Collins was not particularly familiar with psychedelic therapy before joining the Trump administration, the secretary has become one of the most vocal advocates for advancing reform to ease access for veterans.

In July, for example, VA Secretary He proclaimed his mission to promote access to psychedelics for veterans with serious mental health conditions, it was possible to say that it “opened that door wider than most probably thought”.

“I’m the first secretary of the VA—actually, in a cabinet about a month and a half ago— really brought psychedelics to a Cabinet meeting” Collins said at the time. “I think what we need to look at is we need to put the alternatives on the map. The VA will do our job. We will do it within the law and we will do what we have to do.”

The secretary also said in the summer “very open” to expanding access to psychedelic therapy for veterans-he emphasized that he intends to find ways to “cure” people with serious mental illnesses and not just to treat superficial symptoms.

Collins noted that the VA is actively conducting a dozen or so clinical trials either internally or through private partnerships “on a number of different substances where we’re seeing really good results,” among others. One based at VA Bronx Health Care researching MDMA-assisted therapy “Actually, with very good results.”


It’s Marijuana Moment tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

In June, Kennedy said that his agency “Fully committed” to expanding research into the benefits of psychedelic therapy. and, along with the head of the FDA, aims to give military veterans legal access to these substances “within 12 months.”

The secretary also said that in April He had a “wonderful experience” with LSD at the age of 15He took it because he thought they would be able to see dinosaurs, as depicted in a comic he was a fan of.

Last October, Kennedy specifically criticized the FDA under the previous administration for the agency’s “eradication of psychedelics” and a laundry list of other issues that he said was a “war on public health” that would end under the Trump administration.

Photo elements courtesy of the user carlosemmaskype and Apollo.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Cannabis News

Maximizing cannabis yields with intercanopy and subcanopy lighting

Published

on

By







Continue Reading

Cannabis News

Transportation Groups Warn Feds Of Marijuana Rescheduling’s ‘Consequences’ For Drug Testing Of Truck Drivers And Pilots

Published

on

By

A coalition of transportation and safety organizations said they have “serious safety concerns” about the Trump administration’s move to federally regulate marijuana.

Led by the American Trucking Association, the groups sent a letter to federal officials Monday asking them to take steps to ensure truck drivers, pilots, transit operators and other safety-sensitive workers continue to be tested for cannabis.

“If employers do not take the necessary steps to preserve the ability of security-sensitive transportation workers to test for marijuana, this change could have significant consequences for the safety of passengers and the entire transportation industry,” wrote Acting Attorney General Todd Blanche, Drug Enforcement Administration (DEA) Administrator Terrance Cole, Health and Human Services Secretary Robert F. Kennedy, and Transportation Secretary J.

The organizations said they understand that federal officials are being “urgently” reorganized under an executive order from President Donald Trump, that they are “deeply concerned that the current process does not adequately take into account agencies responsible for transportation safety or protecting the traveling public” and that they want the agencies to “work together.” ongoing cannabis redistricting hearings and rulemaking process to address these concerns.

In May, the Department of Transportation (DOT) issued new guidelines saying just that Truck drivers, airline pilots and other safety-sensitive workers still cannot use medical marijuana without penalty despite the Trump administration’s move to reschedule.

“Marijuana use is incompatible with safety-sensitive functions,” the department said.

Medical review officers (MROs) who receive drug test results indicating cannabis use cannot rule them out as negative for illegal substance use, even if an employee claims it was a result of state-licensed medical marijuana.

“Currently, there is no way for an MRO to verify that a laboratory-confirmed marijuana drug test result is positive when an employee claims the positive was caused by a state-licensed marijuana product,” the DOT said, explaining that after the reprogramming, medical marijuana dispensed under state law “does not” constitute a drug approved by the Food and Drug Administration (FDA).

The transportation groups said in the new letter that the DOT’s drug-testing program “is in accordance with the Department of Health and Human Services’ (HHS) Mandatory Guidelines for Federal Workplace Drug Testing Programs and HHS-certified laboratories.”

“While DOT has expressed its intention to continue testing marijuana, a commitment we greatly appreciate, it is unclear whether DOT will retain its ability to rely on HHS procedures and certifications after the rescheduling,” they wrote. “Without this alignment, DOT may retain the authority to conduct testing, but lack the scientific and procedural infrastructure to do so.”

“Practically, this would mean that truck and bus drivers, pilots, flight attendants, air traffic controllers, air mechanics, railroad workers, dispatchers and signal workers, transit operators and pipeline workers could continue to perform high-risk safety roles without a reliable means of verifying that they are not actively using marijuana. It relies on controlled substance testing to identify end use and prevent potentially impaired individuals from fulfilling their safety-related obligations. While the planning could create legal or regulatory loopholes, the regulated employer-based drug testing agency warned that the final rules should not jeopardize marijuana testing for safety-sensitive transportation workers.”

“Regardless of the broader policy goals of the review, the federal government should not move forward to preserve transportation drug testing programs and mitigate the risks of increased and unchecked deterioration of our roads, railroads, public transportation systems, pipelines, airspace, and maritime corridors,” the letter says.

The organizations specifically ask federal officials to:

  • Support long-term marijuana testing for all safety-sensitive transportation workers;
  • Confirm the authority of DOT-regulated employers to perform such tests;
  • Ensure HHS laboratory certification and testing guidelines remain available and aligned with DOT’s safety mission; and
  • Establish a coordinated federal strategy to address the transportation security implications of rescheduling.

“The public and the workers who keep our transportation system running safely deserve a process that ensures these safeguards are firmly in place before any final action is taken,” he said. the letter he says

Earlier this month, the House Appropriations Committee approved a provision to allow federal officials to continue requiring government employees and security-sensitive employees, such as truck drivers and airline pilots must be drug tested for marijuana, “regardless of any future change in legal status or schedule.”

This was followed by a press conference organized by prohibitionist groups and a drug-testing industry association, where both Republican lawmakers joined the proclamation. “Cut” to marijuana rescheduling by asserting that safety-sensitive transportation workers can still be punished for testing positive for THC.

Legislators and abolitionist activists argued that moving marijuana to Schedule III would lead to a 1986 executive order signed by President Ronald Reagan defining illegal drugs under the Controlled Substances Act (CSA) in relation to the use of cannabis by truck drivers and other airline employees.

Last October, Transportation Secretary Sean Duffy suggested that President Donald Trump was “putting pressure” on rescheduling cannabis.arguing that marijuana is “truly addictive” and that policy reform on the issue sends a “dangerous” message.

“At a time when the culture is encouraging and celebrating the use of marijuana, we’re not talking about risk,” Duffy said.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Experts say THC percentage is the wrong way to shop for cannabis

Published

on

By


Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media